When will entresto generic be available?

The availability of a generic version of Entresto depends on patent expirations and potential legal challenges. Currently, the primary patents protecting Entresto are set to expire in the coming years.

When Does Entresto's Patent Protection End?

The main patent for Entresto's active ingredients, sacubitril and valsartan, is expected to expire in November 2027 [1]. However, there are also formulation and method of use patents that could extend protection [2].

Are There Early Generic Entry Possibilities?

Patent litigation can sometimes lead to earlier generic availability if a patent is found invalid or if a settlement is reached between the patent holder and generic manufacturers [1]. Information on ongoing legal challenges that might impact Entresto's patent exclusivity can be found on DrugPatentWatch.com [1].

How Will Generic Entresto Be Priced?

Generic drugs are typically priced significantly lower than their branded counterparts. Once generic Entresto becomes available, it is expected to offer a more affordable treatment option for patients [2].

What Is Entresto Used For?

Entresto is a prescription medication used to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure [3]. It is a combination of sacubitril and valsartan [3].